全球动物保健合作协议条款及条件（2017-2026）

全球动物保健产业合作策略标竿

"动物保健合作（2017-2026）" 报告对全球动物保健产业的合作协议进行了全面分析。该报告专为业务拓展、许可和策略专业人士设计，深入剖析了企业如何建立合作关係，以促进兽药、疫苗、诊断试剂和动物保健技术的研发、商业化和分销。

这份经过全面修订和更新的报告分析了自2017年以来发布的280多项动物保健相关协议，清晰地展现了从研发到商业化的企业间合作现状。这些合作关係通常包含多种要素，从联合研发开始，逐步发展到授权协议、生产协议和商业化协议。

每份协议记录都包含可用的财务资讯以及指向详细线上协议记录的连结。 如果合约已公开备案，本报告还提供直接存取提交给监管机构的合约文件的途径，使用户能够查看合作伙伴之间协商的详细条款。

本报告结合详细的交易数据、财务基准和实际合约文件，为您提供宝贵的见解，帮助您评估动物保健行业的潜在合作伙伴，制定合作协议，并达成更有利的交易。

主要优势

• 显着缩短研究时间

您无需搜寻多个资料库、新闻稿和监管文件，即可存取涵盖数百个动物製药合作专案的统一资源。

• 动物製药交易结构基准分析

了解各公司如何在兽医和动物保健领域建立合作关係，包括联合研发协议、许可协议和商业化合作。

• 自信地分析财务条款

审查关键合约金额、预付款、里程碑付款和特许权使用费等财务交易条款，并对类似合作关係的价值进行基准评估。

• 查阅实际合约文件

如有条件，请查阅已向美国证券交易委员会 (SEC) 提交的实际合作协议，以深入了解通常不公开的详细合约条款。

• 辨识动物保健领域最活跃的交易实体

识别在动物保健领域引领合作活动的关键公司，并分析其合作策略。

• 追踪产业合作趋势

分析自 2017 年以来依技术、治疗领域和开发阶段划分的合作活动，以了解动物保健产业的演变。

回报内容

2017年以来兽药产业合作趋势分析

兽药产业交易结构与财务模式概述

基于交易额的主要兽药合作案例回顾

最活跃的25家兽药交易撮合者的简介

依技术类型、治疗领域和研发阶段分类的交易详细分析

以字母顺序（A-Z）排列的兽药产业合作综合名录

可线上查阅的交易记录和合约文件连结

基于实际合约的尽职调查见解

本报告分析了实际的合作协议，使用户能够评估关键的交易条款，例如：内容如下：

• 授权和开发权
• 财务支付结构与里程碑完成条件
• 智慧财产权所有权和许可范围
• 开发与商业化责任
• 独家条款与地域权
• 合约期限和终止条款
• 合约文件提供了公司间协商的详细条款的宝贵资讯。这些资讯很少在新闻稿或传统交易资料库中披露。
• 本报告的重要性
• 策略伙伴关係对于动物保健产业的创新至关重要，它使公司能够整合技术、分担开发风险并扩大全球商业化能力。
• 本报告透过提供全面的交易数据、财务基准和实际合同，为评估合作机会、建立更牢固的合作关係以及在动物製药领域更有效地进行谈判提供了所需的资讯。

目录

摘要整理

第一章：引言

第二章：动物保健贸易趋势

• 引言
• 长期动物保健伙伴关係
• 最活跃的动物保健贸易商
• 依交易类型划分的动物保健伙伴关係
• 依治疗领域划分的动物保健伙伴关係
• 依技术类型划分的动物保健伙伴关係
• 动物保健合作伙伴关係的合约条款
  • 动物保健伙伴关係的关键价值
  • 动物保健合约的预付款
  • 动物保健交易的里程碑付款
  • 动物保健特许权使用费率

第三章：关键动物保健交易

• 引言
• 以价值为排名的顶级兽药

第四章 - 最活跃的动物保健品交易商

• 引言
• 最活跃的动物保健品交易商
• 最活跃的动物保健品合作伙伴公司简介

第五章 - 动物保健品合约交易目录

• 引言
• 动物保健品合约交易目录

第六章 - 依技术类型划分的动物保健品交易

附录

• 附录 1 - 依公司划分的兽药交易 (AZ)
• 附录 2 - 依研发阶段划分的动物保健品交易
• 附录 3 - 依交易类型划分的动物保健品交易
• 附录 4 -依治疗领域划分的兽医健康交易
• 附录 5 - 交易类型定义
• 附录 6 - 更多信息
• 关于研究公司
• 现有合作伙伴关係
• 现有合约
• 近期合作伙伴发布的报告标题

Benchmark Partnering Strategies Across the Global Animal Health Industry

The Animal Health Partnerships 2017-2026 report provides a comprehensive analysis of partnering agreements across the global animal health sector. Designed for business development, licensing, and strategy professionals, the report delivers detailed insight into how companies structure partnerships to develop, commercialize, and distribute veterinary medicines, vaccines, diagnostics, and animal health technologies.

Fully revised and updated, the report analyzes over 280 animal health agreements announced since 2017, providing a clear view of how companies collaborate across research, development, and commercialization. These partnerships often combine multiple components-beginning with collaborative R&D and progressing through licensing, manufacturing, or commercialization agreements.

Each deal record includes financial information where available and links to detailed online deal records. Where agreements have been publicly filed, the report also provides direct access to contract documents submitted to regulators, enabling users to examine the detailed terms negotiated between partners.

By combining detailed deal data, financial benchmarking, and access to real contract documents, the report provides valuable intelligence for evaluating potential partners, structuring collaboration agreements, and negotiating stronger deals within the animal health industry.

Key Benefits

• Save Significant Research Time

Access a consolidated resource covering hundreds of animal health partnerships rather than searching multiple databases, press releases, and regulatory filings.

• Benchmark Animal Health Deal Structures

Understand how companies structure veterinary and animal health partnerships, including collaborative R&D agreements, licensing arrangements, and commercialization partnerships.

• Analyze Financial Terms with Confidence

Review financial deal terms-including headline values, upfront payments, milestone payments, and royalties-to benchmark the value of comparable partnerships.

• Access Real Contract Documents

Where available, explore actual partnership agreements filed with the SEC, providing insight into detailed contractual provisions that are often not disclosed publicly.

• Identify the Most Active Animal Health Dealmakers

Discover which companies are leading partnering activity across the animal health sector and analyze their collaboration strategies.

• Track Industry Partnering Trends

Analyze partnership activity since 2017 across technologies, therapy areas, and development stages to understand how the animal health industry is evolving.

What's Included in the Report

Analysis of animal health partnering trends since 2017

Overview of animal health deal structures and financial models

Review of the leading animal health partnerships by deal value

Profiles of the top 25 most active animal health dealmakers

Detailed analysis of deals organized by technology type, therapy area, and development stage

A comprehensive directory of animal health partnerships organized by company A-Z

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual partnership contracts, the report enables users to evaluate key deal provisions such as:

• Licensing and development rights
• Financial payment structures and milestone triggers
• Intellectual property ownership and licensing scope
• Development and commercialization responsibilities
• Exclusivity provisions and territorial rights
• Contract duration and termination clauses
• Contract documents provide valuable insight into the detailed terms negotiated between companies-information rarely disclosed in press releases or traditional deal databases.
• Why This Report Matters
• Strategic partnerships are essential to innovation in the animal health industry, allowing companies to combine technologies, share development risk, and expand global commercialization capabilities.
• By providing comprehensive deal data, financial benchmarking, and access to real contract agreements, this report delivers the intelligence needed to evaluate partnership opportunities, structure stronger collaboration agreements, and negotiate more effectively in the animal health sector.

Table of Contents

xecutive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in animal health dealmaking

• 2.1. Introduction
• 2.2. Animal health partnering over the years
• 2.3. Most active animal health dealmakers
• 2.4. Animal health partnering by deal type
• 2.5. Animal health partnering by therapy area
• 2.6. Animal health partnering by technology type
• 2.7. Deal terms for animal health partnering
  • 2.7.1 Animal health partnering headline values
  • 2.7.2 Animal health deal upfront payments
  • 2.7.3 Animal health deal milestone payments
  • 2.7.4 Animal health royalty rates

Chapter 3 - Leading animal health deals

• 3.1. Introduction
• 3.2. Top animal health deals by value

Chapter 4 - Most active animal health dealmakers

• 4.1. Introduction
• 4.2. Most active animal health dealmakers
• 4.3. Most active animal health partnering company profiles

Chapter 5 - Animal health contracts dealmaking directory

• 5.1. Introduction
• 5.2. Animal health contracts dealmaking directory

Chapter 6 - Animal health dealmaking by technology type

Appendices

• Appendix 1 - Animal health deals by company A-Z
• Appendix 2 - Animal health deals by stage of development
• Appendix 3 - Animal health deals by deal type
• Appendix 4 - Animal health deals by therapy area
• Appendix 5 - Deal type definitions
• Appendix 6 - Further reading
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Animal health partnering since 2017
• Figure 2: Active animal health dealmaking activity since 2017
• Figure 3: Animal health partnering by deal type since 2017
• Figure 4: Animal health partnering by disease type since 2017
• Figure 5: Animal health partnering by technology type since 2017
• Figure 6: Animal health deals with a headline value
• Figure 7: Animal health deals with an upfront value
• Figure 8: Animal health deals with a milestone value
• Figure 9: Animal health deals with a royalty rate value
• Figure 10: Top animal health deals by value since 2017
• Figure 11: Most active animal health dealmakers since 2017